课题基金 / 基金详情

Mechanisms of Carcinogenesis in BRCA2 Mutant Cells

Mechanisms of Carcinogenesis in BRCA2 Mutant Cells
BRCA2突变细胞的致癌机制
批准号:
6399060
负责人:
Jeffrey T Holt
金额:
$30.15万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-06-01 至 2002-05-31

项目摘要

项目成果

Jeffrey T Holt的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The BRCA2 gene is a cancer predisposition gene, which is matured in breast cancer, prostate cancer, ovarian cancer, esophageal cancer , and pancreatic cancer. In response to the critique, we have markedly modified this proposal to study mouse BRCA2 defective cells (BRCA2--) instead of human BRCA2 defective Vance cells, since the genetic defect in the mouse cells is simpler. Our preliminary data in mouse BRCA2-- cells shows that Rad51 is rapidly cleaved by caspase-3 in BRCA2 defective cells and that overexpression of BRCA2 or Rad51, or inhibition of caspase-3 reverse radioactivity and the DNA repair defect. A caspase-3 resistant Rad51 mutant (D- A187Rad51) reverses radio sensitivity and the DNA repair in brca2-- to a greater extent than wildtype Rad51 when both proteins are expressed at near physiologic levels. We have recently purified Rad51 and caspase-3 proteins to allow in vitro mechanistic studies. We present new data showing Rad51 is mostly cytoplasmic in brca2--, and that wildtype BRCA2 expression relocates Rad51 to the nucleus whereas mutant BRCA2 expression does not effect Rad51 localization. These fundings lead to the following hypotheses: 1. BRCA2 normally functions in double strand DNA break repair; 2. BRCA2 and Rda51 function in the same biochemical pathway mediating DNA repair; 3. BRCA2 stabilizes Rad51 by inhabiting degradation by caspase-3 and other proteases; 4. BRCA2 influences nuclear localization of Rad51. To test hypothesis we propose these aims. Aim 1: Determine the functional domains of BRCA2 protein which mediate double strand break repair and tumorigenesis. Aim 2: See if known additional mutations in BRCA2 defective cancer cells contribute to radiation sensitivity & DNA repair defects in brca2-- cells. Aim 3: Determine the mechanism and in vivo significance off BRCA2- Rad51 interactions by in vitro assays. Aim 4: Analyze mechanism of BRCA2- Rad51 localization. Aim 5: Develop and use in Vivo imaging methods to study Rad51 localization and DNA repair in living cells, in real time.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IHC Test for BRCA1 Hereditary Ovarian Cancer
  • 批准号:
    8239640
  • 项目类别:
  • 资助金额:
    $39.92万
  • 财政年份:
    2010
  • 负责人:
    Jeffrey T Holt
  • 依托单位:
IHC Test for BRCA1 Hereditary Ovarian Cancer
  • 批准号:
    8259213
  • 项目类别:
  • 资助金额:
    $39.92万
  • 财政年份:
    2010
  • 负责人:
    Jeffrey T Holt
  • 依托单位:
IHC Test for BRCA1 Hereditary Ovarian Cancer
  • 批准号:
    7804771
  • 项目类别:
  • 资助金额:
    $16.36万
  • 财政年份:
    2010
  • 负责人:
    Jeffrey T Holt
  • 依托单位:
PARP Inhibitor Targeted Therapy for Breast Cancer
  • 批准号:
    7481522
  • 项目类别:
  • 资助金额:
    $14.9万
  • 财政年份:
    2008
  • 负责人:
    Jeffrey T Holt
  • 依托单位:
海外基金